About Swift

Swift Biosciences is a biotechnology company that is developing novel molecular biology technologies to better characterize and understand the genome. We are an energetic, highly innovative company focused on creating tools to advance the DNA sequencing sciences. Our products are designed to help customers analyze challenging samples that are often associated with translational work, including circulating, cell-free DNA and formalin-fixed, paraffin-embedded samples.

Swift BioSciences Team

Swift’s innovative team of scientists and executives have a strong track record of joining discovery with function to make new applications and markets. Our product development is purposeful and focused on creating products that are well-regarded by both customers and their intended industries. The mission of Swift is to provide long term improvements in the health of individuals and their communities all around the world, specifically in the fight against cancer and understanding the complexities of inherited diseases. The tools developed in our efforts are directly applicable to research in agrigenomics, biotechnology, metagenomics, and the pharmaceutical industry.

Swift Biosciences entered the Next-Generation Sequencing Market in 2013 and enjoys the collaboration of renowned scientists with a history of successful businesses and the support of experienced life science investors. Our innovation pipeline, developed by our growing team of talented scientists, has generated multiple validated products for translational research across the genomics landscape and we are looking forward to adding new technologies and products to our portfolio.

BOARD OF DIRECTORS

dan kidle

DAN KIDLE

Chairman

Nathan Wood

NATHAN WOOD

President and
Chief Executive Officer

Jack Ball

Jack Ball

Director

Linda Tufts, Director, Swift BioSciences

Linda Tufts

Director

Mark Lewis

Mark L. Lewis

Director

Dan Watkins

Dan Watkins, PhD

Director

Walter Young, Director, Swift BioSciences

Walter Young

Director

Management Team

The Swift Biosciences team combines excellence in science with superior business skills to deliver first-in-class library preparation for next-generation sequencing. The considerable experience, expertise, and commitment of our exceptional leaders and colleagues enable us to extend our impact and achieve success.

Nathan Wood

Nathan Wood

President and Chief Executive Officer

Haley Fiske, Chief Commercial Officer, Swift BioSciences

Haley Fiske

Chief Commercial Officer

Vladimir Makarov, PhD, Chief Scientific Officer, Swift BioSciences

Vladimir Makarov, PhD

Chief Scientific Officer

James Militello, Chief Financial Officer and Treasurer

James Militello

Chief Financial Officer and Treasurer

Laurie Kurihara

Laurie Kurihara, PhD

Vice President, Product Development

Camille Cappello Director, Global Marketing

Camille Cappello

Director, Global Marketing

Christine Haakenson

Christine Haakenson, PhD

Vice President of Operations

Sales Team

Haley Fiske

Chief Commercial Officer

415.481.5095

[email protected]

Kellie Feck

Director of North America Sales

410.292.6878

[email protected]

North America

Nada Abdel-Magid

Senior Business Development Manager, Mid-Atlantic

215.460.0619

[email protected]

Chris Cook

Senior Business Development Manager, South

470.350.7919

[email protected]

Ian Silber

Senior Business Development Manager, Midwest

708.310.1965

[email protected]

William Love

Senior Business Development Manager, Northeast

617.320.0441

[email protected]

Jerell Aguila, PhD

Senior Business Development Manager, West

702.353.0808

[email protected]

Matthew Aspinwall

Senior Business Development Manager, Pacific Northwest

805.807.5112

[email protected]

International

Gerardas Dambrauskas

Director of Commercial Operations, EMEA

447903777875

[email protected]

Jean-Marc Terral

VP of Commercial Operations, APAC

619.739.1051

[email protected]i.com

Mengmeng Lin

Field Applications Specialist, APAC

+86 13537879824

[email protected]